Soligenix
SNGX
#10219
Rank
ยฃ12.2 M
Marketcap
ยฃ1.21
Share price
1.90%
Change (1 day)
-55.78%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -ยฃ9.46 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ7.03 Million a decrease over its 2023 earnings that were of -ยฃ5.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ9.46 Million34.52%
2024 -ยฃ7.03 Million22.96%
2023 -ยฃ5.72 Million-45.74%
2022 -ยฃ10.54 Million11.88%
2021 -ยฃ9.42 Million-32.37%
2020 -ยฃ13.92 Million83.18%
2019 -ยฃ7.6 Million11.57%
2018 -ยฃ6.82 Million19.29%
2017 -ยฃ5.71 Million33%
2016 -ยฃ4.3 Million-19.7%
2015 -ยฃ5.35 Million5.16%
2014 -ยฃ5.09 Million
2010 -ยฃ5.74 Million26.12%
2009 -ยฃ4.55 Million75.1%
2008 -ยฃ2.6 Million-45.38%
2007 -ยฃ4.76 Million-22.84%
2006 -ยฃ6.17 Million66.15%
2005 -ยฃ3.72 Million-16.65%
2004 -ยฃ4.46 Million13.28%
2003 -ยฃ3.93 Million-11.88%
2002 -ยฃ4.46 Million-59.44%
2001 -ยฃ11 Million378.18%
2000 -ยฃ2.3 Million-38.53%
1999 -ยฃ3.75 Million-18.43%
1998 -ยฃ4.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cleveland BioLabs
CBLI
-ยฃ2.07 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.84 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ8.91 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.35 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.4 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ13.65 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.33 B-14,426.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel